Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Weidingkang Soft Capsule** is an oral traditional Chinese herbal medicine product developed by China Resources Kunming Shenghuo Pharmaceutical for duodenal ulcer, including the traditional Chinese medicine blood-stasis and heat pattern. Completed Phase 2 studies evaluated ulcer healing, safety, and *Helicobacter pylori* clearance. Public company communications characterize the product as a Sanchi-based preparation and attribute putative anti-*H. pylori*, gastrointestinal antispasmodic, and anti-inflammatory actions to the product; however, its complete active composition, molecular targets, and target-level pharmacology are not publicly established. ([synapse.patsnap.com](https://synapse.patsnap.com/drug/62305a9e2b784a688f4b8302abc14d57))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Weidingkang Soft Capsule.